1月10日，中国眼健康产业园联盟大会暨国际智能医工创新中心成果汇报会在昌平区中国高端医疗装备 创新与高质量发展交流中心举办。北京市医疗保障局党组成员、副局长王瑞超，国家眼耳鼻喉疾病临床 医学研究中心主任、中国眼谷理事长瞿佳，区委副书记、区长，未来科学城党工委副书记、管委会主任 刘晓东出席。 关于中国眼健康产业园联盟 中国眼健康产业联盟由中国眼谷牵头组建，浑南区光明小镇与北京中关村、爱尔眼科等10家眼健康产业 龙头单位成为首批联盟单位。该联盟旨在汇聚国内顶尖眼科产业园区共同建立常态化合作机制，在资源 共享、产业协同、政策突破与资本联动等方面凝聚共识，携手打造引领中国、影响世界的眼健康产业生 态。 关于国际智能医工创新中心： 国际智能医工创新中心(GMEC)由北京清华工业开发研究院、中国医学装备协会和中关村科技园区昌平 园管理委员会联合指导，中国眼谷、昌发展集团等十余家企业共同支持，图湃医疗和全球健康产业创新 中心联合承办，中心位于昌平区国际医疗器械城——图湃医疗新全球总部，致力打造以企业为主体的智 能医疗装备创新转化基地，高效推动产、学、研、医融合转化，创造临床价值与社会价值。 关于图湃医疗： 图湃医疗成立于2 ...

Core Viewpoint - The article highlights the rapid development and investment trends in China's high-end medical device sector, driven by supportive government policies and increasing domestic innovation in medical technology [3][7][8]. Industry Overview - China's medical device sector is transitioning from low-end consumables to high-end equipment, with significant international recognition for products like endoscopes and MRI machines [7]. - As of July 18, 2025, 46 innovative medical devices have been approved for market entry, with expectations for a record number by the end of the year [3][7]. - The second quarter of 2025 saw a total of 151 financing cases in the medical device sector, with disclosed financing amounts reaching 3.408 billion yuan, indicating a stable investment climate [18]. Investment Dynamics - In Q2 2025, the medical device sector experienced a slight decrease in financing cases by 2.58% compared to the previous quarter, with a significant drop of 55.51% in disclosed financing amounts [18]. - The medical equipment segment attracted the most investor interest, with 74 financing cases totaling 1.293 billion yuan, particularly in treatment and rehabilitation devices [18]. - Early-stage financing (angel to A rounds) accounted for 62.25% of cases, while mid to late-stage financing (B to E rounds) made up 37.75%, indicating a trend towards smaller, earlier investments [19]. Key Financing Events - Notable financing events in Q2 2025 included Core Medical's over 1 billion yuan in D round financing and significant investments in various medical device companies [12][30]. - The financing landscape is characterized by a concentration in developed regions such as Jiangsu, Shanghai, and Guangdong, which collectively accounted for 80.79% of financing cases [20]. Industry Trends - The demand for ophthalmic medical devices is rising due to an aging population and increasing prevalence of eye diseases, with the market expected to grow significantly [32][35]. - The domestic market for ophthalmic devices is seeing a shift towards local production, with government policies encouraging the procurement of domestic medical equipment [37]. - The global ophthalmic device market is projected to reach 67.14 billion USD by 2032, reflecting strong growth potential [39].

Core Insights - The article highlights the increasing participation of domestic medical equipment in the ophthalmology sector, particularly in basic examinations, auxiliary diagnostics, AI imaging, and surgical support equipment, indicating a shift towards domestic and AI-driven solutions in the market [1][3]. Summary by Sections Market Trends - The procurement trends for the second half of the year will focus on domestic production, AI integration, and penetration into lower-tier markets [1]. Procurement Overview - In the past week, there were 13 different procurement units involved, including top-tier hospitals and county-level hospitals, indicating a diverse range of buyers [3]. - The procurement involved nearly 20 different types of ophthalmic equipment, covering basic examination tools, imaging and diagnostic devices, and surgical treatment instruments [3]. Brand Participation - A total of 22 brands were involved in the procurement, with domestic brands accounting for nearly 60% of the total, showcasing the growing influence of local manufacturers [3]. Financial Highlights - The total bid amount reached 18.743 million yuan, with the highest single equipment bid amounting to 3.2779 million yuan, reflecting significant investment in ophthalmic technology [3].

将向科创板眼科医疗设备"第一股"发起冲击。 本文为IPO早知道原创 作者｜Stone Jin 微信公众号｜ipozaozhidao 据IPO早知道消息，图湃医疗日前完成由社保基金中关村自主创新专项基金(由君联资本担任管理 人)、北京机器人产业投资基金、启明创投共同投资的总规模达5亿元人民币级别E轮融资。 这是继2024年6月完成D轮融资后，图湃医疗一年内再受顶级投资机构青睐。 ， 也是 国内 眼科医 疗设备领域历史上已公开一级市场投融资事件中单笔金额最高的融资 ，所融资金将持续用于图湃医 疗丰富产品矩阵及加强全球范围的市场布局等。 在完成本次E轮融资后，图湃医疗将向科创板眼科医疗设备"第一股"发起冲击。 图湃医疗始于清华大学电子工程系的科技成果转化。公司创始人、清华大学霍力教授2008年在约翰 霍普金斯大学做博士后期间就开始从事扫频OCT研究，师从Xingde Li教授，后者是OCT发明人 James G. Fujimoto教授的学生。在国家自然科学基金等多个科研项目的支持下，霍力教授带领团 队实现了一系列关键底层技术的突破和自主化。 图湃医疗成立后，眼科OCT在北京清华工业开发研究院医工转化体系中，迅速完成 ...